Journal article
Downregulation of IgE antibody and allergic responses in the lung by epidermal biolistic microparticle delivery
Journal of Allergy and Clinical Immunology, Vol.117(2), pp.275-282
2006
Abstract
Background
Biolistic injections provide a needle-free delivery of antigen-laden microparticles to the epithelium. The precision of the injection preferentially targets the Langerhans cell network, which, although ideal for vaccination, might not be suitable for the downregulation of immune responses in immunotherapy.
Objective
We sought to determine the ability of biolistic injection of antigen into the epithelium of sensitized mice to inhibit IgE antibody and lung inflammatory responses produced by further exposure to antigen.
Methods
Mice were sensitized by means of a needle injection of ovalbumin (OVA) in alum and given a series of biolistic injections of OVA or vehicle control, followed by a boost of OVA in alum. Serum IgE and IgG antibodies were measured before and after the boost. The mice were then challenged intranasally, and the infiltration of inflammatory cells was measured by means of bronchoalveolar lavage. Airway reactivity of the challenged mice was measured by examining responses to methacholine with forced oscillatory techniques.
Results
Biolistic injection of OVA into the dorsal skin of sensitized mice markedly inhibited IgE and IgG1 antibody responses induced by boosting. IgG2a antibody responses were reduced rather than stimulated. The eosinophilic inflammation in the bronchoalveolar lavage fluid induced by intranasal challenge was also markedly inhibited. Lung hyperreactivity showed an initial increase and then a decrease of responsiveness to methacholine, with elastance returning to the level of unsensitized mice. Biolistic injection into the buccal epithelium was also inhibitory.
Conclusions
Biolistic injection of allergen inhibited the boosting of IgE antibody and eosinophilic lung inflammatory responses without inducing TH1 immunity.
Details
- Title
- Downregulation of IgE antibody and allergic responses in the lung by epidermal biolistic microparticle delivery
- Authors/Creators
- M. Kendall (Author/Creator)T.J. Mitchell (Author/Creator) - University of OxfordG. Costigan (Author/Creator) - University of OxfordM. Armitage (Author/Creator) - University of OxfordJ.C. Lenzo (Author/Creator) - The Kids Research Institute AustraliaJ.A. Thomas (Author/Creator) - The Kids Research Institute AustraliaC. von Garnier (Author/Creator) - The Kids Research Institute AustraliaG.R. Zosky (Author/Creator) - The Kids Research Institute AustraliaD.J. Turner (Author/Creator) - The Kids Research Institute AustraliaP.A. Stumbles (Author/Creator) - The Kids Research Institute AustraliaP.D. Sly (Author/Creator) - The Kids Research Institute AustraliaP.G. Holt (Author/Creator) - The Kids Research Institute AustraliaW.R. Thomas (Author/Creator) - The Kids Research Institute Australia
- Publication Details
- Journal of Allergy and Clinical Immunology, Vol.117(2), pp.275-282
- Publisher
- Mosby Inc.
- Identifiers
- 991005544038707891
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
34 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 2 Chemistry
- 2.176 Drug Delivery Chemistry
- 2.176.771 Transdermal Delivery
- Web Of Science research areas
- Allergy
- Immunology
- ESI research areas
- Immunology